122 related articles for article (PubMed ID: 5444338)
1. An analogue of guinea pig C8: in vitro generation and inhibitory activity.
Stolfi RL
J Immunol; 1970 May; 104(5):1212-9. PubMed ID: 5444338
[No Abstract] [Full Text] [Related]
2. Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.
Tamura N; Nelson RA
J Immunol; 1967 Sep; 99(3):582-9. PubMed ID: 6051385
[No Abstract] [Full Text] [Related]
3. Inhibition of guinea pig complement by aromaticamidine and guanidine compounds.
Bing DH
J Immunol; 1970 Nov; 105(5):1289-91. PubMed ID: 5489072
[No Abstract] [Full Text] [Related]
4. Inhibition of the eighth component of complement (C8) by ethylenediaminetetra-acetate (EDTA).
Schultz DR; Zarco RM
J Immunol; 1970 Feb; 104(2):279-88. PubMed ID: 4983887
[No Abstract] [Full Text] [Related]
5. [C1-inactivator from guinea pig serum-mechanism of action. I. Effect of the inactivator on C1 in free solution].
Loos M; Opferkuch W; Wagner H
Z Med Mikrobiol Immunol; 1971; 156(2):208-20. PubMed ID: 4995250
[No Abstract] [Full Text] [Related]
6. An antigen density effect on the hemolytic efficiency of complement.
Linscott WD
J Immunol; 1970 May; 104(5):1307-9. PubMed ID: 4192162
[No Abstract] [Full Text] [Related]
7. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
Ruddy S; Austen KF
J Immunol; 1969 Mar; 102(3):533-43. PubMed ID: 5813010
[No Abstract] [Full Text] [Related]
8. The fifth component of the guinea pig complement system. 3. Dissociation and transfer of C5b, and the probable site of C5b fixation.
Shin HS; Pickering RJ; Mayer MM
J Immunol; 1971 Feb; 106(2):480-93. PubMed ID: 5545154
[No Abstract] [Full Text] [Related]
9. [The C1-inactivator of guinea pig serum: titration, purification and characterization of the inactivator].
Opferkuch W; Loos M; Ringelmann R
Z Med Mikrobiol Immunol; 1971; 156(2):194-207. PubMed ID: 4995249
[No Abstract] [Full Text] [Related]
10. Inhibition of the lytic effect of guinea pig complement by rabbit complement.
Kempf RA; Gigli I; Austen KF
J Immunol; 1969 Apr; 102(4):795-803. PubMed ID: 5768190
[No Abstract] [Full Text] [Related]
11. [In vitro inhibitory effect of phenylbutazone on the hemolytic activity of complement in guinea pigs].
Lang JM; Hainaut J
Agressologie; 1972; 13(2):117-20. PubMed ID: 5078837
[No Abstract] [Full Text] [Related]
12. Inhibition of guinea pig complement by maleopimaric acid and other derivatives of levopimaric acid.
Glovsky MM; Becker EL; Halbrook NJ
J Immunol; 1968 May; 100(5):979-90. PubMed ID: 5648478
[No Abstract] [Full Text] [Related]
13. Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action.
McLeod B; Baker P; Gewurz H
Immunology; 1975 Jan; 28(1):133-49. PubMed ID: 1116868
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory activity of ninhydrin on the hemolytic activity of guinea pig complement].
Schena L; Piacentini I; Bonomi U
Fracastoro; 1971; 64(4):236-41. PubMed ID: 5003309
[No Abstract] [Full Text] [Related]
15. [Studies on the temperature-dependant denaturation of guinea pig complement].
Sugama T
Nihon Hoigaku Zasshi; 1966 Sep; 20(5):488-95. PubMed ID: 6010573
[No Abstract] [Full Text] [Related]
16. The attack phase of human complement: differentiation between membrane binding and complex formation by the detection of neoantigen expression in situ. A morphometric immunoferritin study.
Balkarowa-Ständer J; Rother U; Rauterberg EW
J Immunol; 1981 Sep; 127(3):1089-93. PubMed ID: 7264298
[TBL] [Abstract][Full Text] [Related]
17. Further studies on the C3b inactivator or conglutinogen activating factor (KAF).
Lachmann PJ; Nicol P; Aston WP
Immunochemistry; 1973 Oct; 10(10):695-700. PubMed ID: 4202955
[No Abstract] [Full Text] [Related]
18. [Preparation of the 3d component of guinea pig cmplement (C3)].
Takahashi S; Okada H; Nishioka K
Arerugi; 1970 Dec; 19(12):859-67. PubMed ID: 5531032
[No Abstract] [Full Text] [Related]
19. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
Hänsch GM; Hammer CH; Mayer MM; Shin ML
J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
[TBL] [Abstract][Full Text] [Related]
20. Complement associated peptidase activity of guinea pig serum. I. Role of complement components.
Cooper NR; Becker EL
J Immunol; 1967 Jan; 98(1):119-31. PubMed ID: 6018765
[No Abstract] [Full Text] [Related]
[Next] [New Search]
